Complementary DNA (cDNA) from human brain tissue is a central molecular resource for neuroscience and genomics. Unlike genomic DNA, cDNA is synthesized from messenger RNA (mRNA) transcripts, reflecting the active genes in brain cells at the time of tissue collection. High-quality brain cDNA enables studies of gene expression, identification of novel transcripts, and functional analyses that are pivotal for understanding brain development, function, disease mechanisms, and therapeutic discovery.

Applications of Human Brain cDNA

• Gene Discovery and Annotation: Large-scale sequencing of brain cDNA identifies novel brain-expressed genes and alternative splicing events, greatly expanding the catalog of human neural genes.
• Transcriptomics and Expression Profiling: cDNA serves as the template for microarrays or next-generation sequencing (RNA-seq), enabling expression analysis across brain regions, developmental stages, and disease conditions.
• Disease Research: Comparison of brain cDNA from control and diseased tissue (e.g., Alzheimer’s, schizophrenia) identifies altered gene expression or disease-specific transcript variants.
• Functional Genomics: Cloned brain cDNAs can be used for in vitro protein expression, functional assays, and structure-function analyses of brain-specific proteins.
• Marker and Polymorphism Discovery: cDNAs may contain sequence polymorphisms and microsatellites, supporting linkage studies and the integration of genetic and expression maps.
• Microarray and Molecular Tool Development: Brain cDNA enables the creation of tissue-specific microarrays for high-throughput studies of gene expression, neurotoxicity, and drug effects.

Human brain cDNA is an indispensable tool for unraveling the active genetic landscape of the nervous system. Its applications span discovery of new genes, disease research, functional genomics, and development of diagnostics and therapeutics. Advances in cDNA library construction, sequencing, and bioinformatics continue to enhance our understanding of brain complexity and the molecular underpinnings of brain health and disease.